Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficiency (Details Narrative)

v3.8.0.1
Stockholders' Deficiency (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 29, 2017
Aug. 25, 2017
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Aug. 04, 2017
Number of shares issued during period, shares         230,000      
Number of shares issued during period         $ 230,000      
Reverse split of issued and outstanding common stock         1-for-50 reverse split      
Change in fair value of warrant liabilities     $ (72,101,423) $ (255,788) $ (72,882,216) $ (2,450,045)    
Loss on inducement expense     5,700,000   5,700,000      
Stock based compensation     322,426 $ 305,458 $ 1,432,832 $ 1,147,496    
Unrecognized stock option weighted average remaining vesting period         1 month 13 days      
Unrecognized stock based compensation expense related to stock option     1,358   $ 1,358      
Director [Member]                
Number of shares issued during period, shares         10,000      
Number of shares issued during period         $ 90,000      
Executive Chairman [Member]                
Number of warrant to purchase of common stock shares 3,100,000              
Received shares of common stock 2,990,404              
Change in fair value of warrant liabilities     $ 43,900,000          
Warrant Holders [Member]                
Number of shares issued during period, shares     710,841          
Number of shares issued during period     $ 8,000,000          
Number of warrant to purchase of common stock shares     180,533   180,533      
Proceeds from issuance of warrant     $ 2,300,000          
Consulting Fee Agreement [Member]                
Number of shares issued during period, shares         21,166      
Series C Convertible Preferred Stock [Member]                
Stock issued during period value stock dividend             $ 1,150,100  
Warrants [Member]                
Number of warrant to purchase of common stock shares               48,023
Shares converted into stock   90,926            
Exchange of Warrants and Series C Convertible Preferred Stock [Member] | Warrant Holders [Member]                
Number of shares issued during period, shares     180,533          
Number of shares issued during period     $ 3,000,000          
Proceeds from issuance of warrant     600,000          
Loss on inducement expense     2,400,000   $ 2,400,000      
Series B Convertible Preferred Stock [Member]                
Number of shares redeemed during period             2,750  
Number of shares redeemed during period, value             $ 275,000  
Preferred stock liquidation preference     825,000   $ 825,000      
Series C Convertible Preferred Stock [Member]                
Number of shares issued during period, shares         70,006      
Number of shares issued during period         $ 7,027,000      
Stock issued during period value stock dividend         848,900      
Accrued and unpaid dividends     $ 22,955,100   $ 22,955,100      
Warrant exercise price     $ 35.00   $ 35.00      
Shares converted into stock         12,678      
Preferred stock description         The Warrant Exchange is effective immediately and the Series C Preferred Stock Exchange is effective upon the closing of the public offering (collectively defined as a public offering of securities to raise up to $20,000,000 and to list the Company’s shares of common stock on the NASDAQ). The Series C Preferred Stock shall be exchanged for common stock using the following formula: the number of shares of Series C Convertible Preferred Stock owned multiplied by a factor of 115 and divided by 80% of the price per share of common stock sold in the in the public offering. Certain holders also agreed to not, without prior written consent of the underwriter, sell or otherwise transfer any shares of common stock or any securities convertible into common stock for a period of 270 days from the effective date of the Series C Preferred Stock Exchange.      
Series C Convertible Preferred Stock [Member] | Warrants [Member]                
Number of shares issued during period, shares         90,926      
Number of warrant to purchase of common stock shares     92,176   92,176      
Warrant exercise price     $ 35.00   $ 35.00